Literature DB >> 11754731

Purification and characterization of a human pancreatic adenocarcinoma mucin.

Ali M Khorrami1, Amit Choudhury, Mahefatiana Andrianifahanana, Grish C Varshney, Sambhu N Bhattacharyya, Michael A Hollingsworth, Bernard Kaufman, Surinder K Batra.   

Abstract

Pancreatic mucins consist of core proteins that are decorated with carbohydrate structures. Previous studies have identified at least two physically distinct populations of mucins produced by a pancreatic adenocarcinoma cell line (HPAF); one is the MUC1 core protein, which includes an oligosaccharide structure identified by a monoclonal antibody (MAb) recognizing the DU-PAN-2 epitope. In this study, we purified and characterized a second mucin fraction, which also shows reactivity with the DU-PAN-2 antibody, but which has an amino acid composition that is not consistent with the MUC1 core protein. This new mucin was purified by ammonium sulfate precipitation, molecular sieve chromatography, and density gradient centrifugation. It eluted in the void volume of a Sepharose 4B column together with an associated low molecular weight protein, which could be further resolved. The mucin is highly polyanionic due to numerous sulfated and sialylated saccharide chains. Carbohydrate analyses of the purified mucin showed the presence of galactose, glucosamine, galactosamine, and sialic acid, but no mannose, glucose, or uronic acid. The purified and deglycosylated mucin shows no reactivity with anti-MUC1 apomucin antibody, but reacts with antiserum against deglycosylated tracheal mucins and antiserum against the MUC4 tandem repeat peptide. Analysis of mucin expression in HPAF cells revealed high levels of MUC1 and MUC4 mRNA, and moderate levels of MUC5AC and MUC5B mRNA. The amino acid composition of the purified mucin shows a high degree of similarity to the MUC4 core protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754731     DOI: 10.1093/oxfordjournals.jbchem.a003073

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

Review 1.  Structure, evolution, and biology of the MUC4 mucin.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Surinder K Batra
Journal:  FASEB J       Date:  2007-11-16       Impact factor: 5.191

Review 2.  Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function.

Authors:  Albert S B Edge
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 3.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

4.  In vivo effect of wood smoke on the expression of two mucin genes in rat airways.

Authors:  Sambhu N Bhattacharyya; Michael A Dubick; Loudon D Yantis; John I Enriquez; Kelvin C Buchanan; Surinder K Batra; Rebecca A Smiley
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

5.  Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles.

Authors:  Andreas Sundgren; Joseph J Barchi
Journal:  Carbohydr Res       Date:  2008-05-08       Impact factor: 2.104

6.  Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells.

Authors:  N Moniaux; P Chaturvedi; G C Varshney; J L Meza; J F Rodriguez-Sierra; J-P Aubert; S K Batra
Journal:  Br J Cancer       Date:  2007-06-26       Impact factor: 7.640

7.  Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedback loops signaling.

Authors:  Yi Zhu; Jing-Jing Zhang; Kun-Ling Xie; Jie Tang; Wen-Biao Liang; Rong Zhu; Yan Zhu; Bin Wang; Jin-Qiu Tao; Xiao-Fei Zhi; Zheng Li; Wen-Tao Gao; Kui-Rong Jiang; Yi Miao; Ze-Kuan Xu
Journal:  J Transl Med       Date:  2014-11-04       Impact factor: 5.531

8.  NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling.

Authors:  Yi Zhu; Jing-Jing Zhang; Yun-Peng Peng; Xian Liu; Kun-Ling Xie; Jie Tang; Kui-Rong Jiang; Wen-Tao Gao; Lei Tian; Kai Zhang; Ze-Kuan Xu; Yi Miao
Journal:  Oncotarget       Date:  2017-02-07

9.  MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.

Authors:  Yukihiro Tamura; Michiyo Higashi; Sho Kitamoto; Seiya Yokoyama; Masahiko Osako; Michiko Horinouchi; Takeshi Shimizu; Mineo Tabata; Surinder K Batra; Masamichi Goto; Suguru Yonezawa
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

Review 10.  Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.

Authors:  N Moniaux; M Andrianifahanana; R E Brand; S K Batra
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.